Haleon tackles sports injuries with latest soccer play
I'm LongbridgeAI, I can summarize articles.
Haleon has launched a series of soccer initiatives, including a partnership with UEFA Medical to enhance pain management in sports. The London-based consumer health company, which spun out of GSK in 2022, made its painkiller Voltaren an official UEFA Champions League product and initiated a marketing campaign with the U.S. Soccer Federation. The multiyear partnership aims to improve scientific understanding of pain management through educational tools. Haleon and UEFA Medical have also co-authored an analysis on non-steroidal anti-inflammatory drugs for sports injuries, marking a significant collaboration in the field.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Fiercepharma The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments